Objective: To review the literature regarding the use of animal models in research addressing psychosomatic aspects of diabetes.
INTRODUCTION
Diabetes mellitus is a metabolic disease in which there is abnormal glucose homeostasis as a result of a defect in insulin secretion or action. Type I (insulin-dependent) and type II (non-insulin-dependent) diabetes mellitus are the commonly recognized forms of the disease. It is estimated that over 14 million Americans have diabetes with 13 million cases of type II diabetes and between 500,000 to 1 million cases of type I diabetes (1) . Because type II diabetes is associated with aging, this form of the disease is becoming more and more prevalent. Approximately 15% of all American adults over 65 are thought to have the disease (1) .
In patients with type I diabetes, the beta, or insulinproducing, cells in the islets of Langerhans contained in the pancreas are targeted and destroyed by the body's own immune system (2) . Without insulin, glucose cannot be utilized by most somatic tissue (the brain is one organ which does not require insulin to metabolize glucose), and protein and fat are metabolized instead. Increases in fat metabolism in diabetes produce large amounts of ketoacids, which if left untreated can lead to death. The tendency to develop this immune response is inherited, but as only 50% of identical twins are concordant for type I diabetes, environmental factors must also play a role (2) .
Type II diabetes is a heterogenous group of conditions in which insulin secretion is not absolutely compromised. Some individuals with this form of the disease retain significant beta cell function, but the insulin target cells are not normally responsive to insulin (termed "insulin resistance"). In other type II patients, insulin resistance may be minimal, the primary problem being that the pancreas does not secrete adequate quantities of insulin in response to glucose stimulation (3) . Some patients with type II diabetes require the addition of exogenous insulin; however, the disease can usually be treated by a controlled diet, weight reduction (which reduces insulin resistance), a regular exercise program, and/or oral medications which stimulate additional insulin secretion and reduce insulin resistance.
STRESS AND DIABETES
One psychosomatic factor long suspected to play a role in diabetes is psychological stress. The thesis that stress could contribute to the etiology of diabetes mellitus was first put forth by Thomas Willis in 1689. He noted that stress seemed to precede the appearance of diabetes in many of his patients (4) . By the nineteenth century, the role of stress in the etiology of diabetes had become firmly established in the medical literature. Henry Maudsley observed that diabetes often followed the occurrence of a sudden trauma (5) . William Osier felt that stress was particularly important in what he termed, diabetes of obesity, noting that "In true diabetes, instances of cure are rare. On the other hand, the transient or intermittent glycosuria met with in stout overfeeders, or in persons who have undergone a severe mental strain, is very amenable to treatment" (6) . Interestingly, among the treatments he prescribed for this type of diabetes were rest and opiates.
CLINICAL STUDIES OF THE ROLE OF STRESS IN DIABETES
The adverse effects of stress on both the development and course of diabetes has been frequently reported in the modern medical literature and has been reviewed by us as well as others (7) (8) (9) . Physical stressors, such as illness, trauma, or rapid metabolic changes, have been shown to cause hyperglycemia and eventual ketoacidosis in type I diabetes (10, 11) . Furthermore, insulin-dependent diabetic children have been shown to demonstrate elevated blood glucose and more rapid ketone release after epinephrine infusion compared to normal children (12) . However, the experimental investigation of the effects of psychological stress on diabetes has produced as many questions as answers. Experimental stress situations are much less evocative than reallife stress and many have employed psychiatric interviews (13) (14) (15) or hypnosis (16) as stressors. Other investigators have looked at the effects of recent negative life events on diabetic control with some finding stress effects while others have not (17) . The most controlled studies using public speaking as a stressor have failed to find significant effects of stress on short-term glucose control (18, 19) .
THE NEED FOR ANIMAL STUDIES
The discordant results on the effects of stress on diabetes in the human literature is in part due to the lack of control inherent in these sorts of investigations. Patient characteristics, such as specific diagnosis, disease duration, presence of neuropathy, and so forth, vary from study to study. Epidemiologic or retrospective studies lack control, and experimental stressors are of limited intensity and relevance to real-life stress. Finally, long-term stress effects are almost impossible to model and study in human populations. Animal studies allow for tight control over experimental conditions, which is typically not feasible in human research. Given the relatively short life spans of many animal models, lifetime developmental issues can be examined in a manner not possible in human studies. Animals that are identical genetically can be produced to control for genetic factors in behavioral studies or to enable the delineation of genetic contributions to disease development and progression. The nutritional content of food can be manipulated, and eating behavior and activity levels can be measured directly in animal models. In the following sections, recent developments in the use of animal models of diabetes and obesity are described, and the implications of this research for future human research and treatment are discussed.
HISTORICAL BACKGROUND FOR THE USE OF ANIMAL MODELS IN DIABETES RESEARCH
Walter B. Cannon made the first appeal for the experimental study of how stress affects diabetes. He noted that the complications from diabetes, such as neuropathy, in humans made studies of the emotional aspects of the disease questionable. To study the problem experimentally, Cannon (20) provoked stress-induced hyperglycemia in normal cats. Cats were confined in a holder and exposed to a stressful stimulus (a barking dog). Urine samples were taken before and throughout the presentation of the stimulus. Before the presentation of the stimulus, no sugar was present for any of the animals. However, he noted that animals who seemed distressed upon encountering the stressful stimulus developed glycosuria more quickly than calm animals.
This observation in animals was attributed to the "fight or flight" response. In order to mobilize energy, the central nervous system stimulates increases in circulating levels of catecholamines, glucocorticoids, and growth hormone. The energy-mobilizing effects of stress can be deleterious to the control of blood glucose in a patient with diabetes, in that glucoregulation is compromised (21, 22) . Therefore, it is theoretically important to consider the extent to which environmental stress and other behavioral variables contribute to blood glucose control in the clinical management of this disorder.
ROLE OF STRESS IN ANIMAL MODELS OF TYPE I DIABETES
Stress may affect the "onset" of type I, or insulindependent diabetes as indicated by numerous animal studies. Animals that have had 80 to 90% of their pancreas removed surgically have been shown to develop either transient or permanent diabetes after restraint stress (23) . Restraint stress produced transient or permanent diabetes in 25 to 28% of pancreatectomized animals, but none of the control animals developed diabetes. Although some animals that were not surgically altered became hyperglycemic after the stressor, none became diabetic. In more recent studies, B-cell cytotoxins, such as alloxan and strep tozotocin., have been used to chemically alter the pancreas instead of surgical procedures. Partial or complete destruction of pancreatic beta cell mass can be produced by controlling the dosage of these cytotoxic agents, thus mimicking aspects of type II and type I diabetes, respectively. Stress can also have the opposite effects in diabetes development. Huang et al. (24) found that light-shock stimulation could inhibit the development of streptozotocininduced diabetes in young mice receiving a single dose of streptozotocin. Further, it has been found that administration of exogenous steroids can inhibit the development of another streptozotocin-induced model of diabetes (25) . One hypothesis is that the adrenal corticotrophic effects of stress mediated the protective effect of shock on the development of diabetes observed in animals treated with streptozotocin.
Another animal model of type I diabetes is the diabetes-prone BB Wistar rat (26) . By the time they are 5 months old, a significant percentage of these animals spontaneously develop an autoimmune insulitis resulting in diabetes. The effects of behavioral stressors such as restraint and crowding have been found to lower the age of onset of diabetes (27) . Lehman et al. (28) found that a greater percentage of animals became diabetic after stress compared to unstressed controls. Some caution must be used, however, in generalizing these findings to humans as BB rats possess other endocrine and immune system abnormalities.
ROLE OF STRESS IN ANIMAL MODELS OF TYPE II DIABETES
Although it is now known that autoimmune destruction of the pancreatic beta cells is involved in type I diabetes, the pathophysiology of type II diabetes remains undetermined. It has been suggested that type II diabetes is due either to a primary defect in the beta cell, making it less responsive to glucose stimulation, or to severe insulin resistance, which eventually exhausts beta cell function (29) . Thus far, however, attempts to find a defect in the beta cell or a mechanism for insulin resistance in somatic cells have been not been successful. Further, no defects have been found upon examination of genes that code for insulin production or insulin receptor expression (30) . Over the last decade, there has been speculation that the autonomic nervous system is involved in the pathophysiology of type II diabetes (31) (32) (33) (34) (35) . Historically, Claude Bernard found that hyperglycemia could be produced in normal rabbits by lesioning the area of the hypothalamus. Bernard's technique was crude, however, and it is not clear that the lesions were specific to the hypothalamus. More recently, several researchers have shown that hyperglycemia can be produced by chemical stimulation of the brain with morphine and by a variety of endogenous neuropeptides and can be abolished by bilateral adrenalectomy (31, 36) . Slow intravenous infusion of epinephrine results in hyperglycemia (37) , as does the type of stress that produces prolonged sympathetic discharge (38) . Autonomic activity leading to metabolic decompensation could be stimulated by stress (35) , or by the effects of dietary fat and carbohydrate on sympathetic outflow (eg, Refs. 39 and 40).
We began our studies on the effects of stress on diabetes utilizing the genetically obese mouse (C57BL/6J, ob/ob). This animal models the characteristics of type II diabetes such as obesity, hyperinsulinemia, insulin resistance, hyperglycemia, and glucose intolerance (41) . However, at the time we began our experiments, there was some controversy over the degree to which the obese mouse was hyperglycemic. Different laboratories have reported varying "basal" plasma glucose levels ranging from 7.28 mM to over 16.8 mM (42-44) . In an early study (45), we demonstrated that the degree of hyperglycemia is dependent, in part, on whether the animal is exposed to stressful environmental stimuli. In the first experiment, blood samples were drawn from obese and lean mice after either a rest period or exposure to stress. Stress consisted of restraint in a wire mesh cage for 60 minutes punctuated by a 5-minute period of shaking. Both lean and obese animals had an increase in plasma glucose levels produced by the stress. This effect was significantly greater in the obese animals than in their lean littermates. Similarly, although plasma insulin decreased in all animals after stress, the decrease was significantly greater in obese animals. In a later study, we found that stress hyperglycemia could easily be classically conditioned in ob/ob mice (46). ob/ob and control animals were exposed to a shaking stress that was either contingently paired or randomly paired with a metronome. After seven trials, ob/ob mice showed a robust conditioned hyperglycemia to the metronome alone, whereas lean controls showed no conditioning at all.
In a final study in this series, we examined the effects of social stress on blood glucose in ob/ob mice and control animals. We modified a chronic stress paradigm used by Henry and Stephens (47) to induce hypertension in mice in order to determine if this same stress would elevate blood sugar in our diabetic animals (48). Ob/ob mice and controls from two different strains were raised in one of two conditions; group housing with five mice of the same strain to a cage, or group housing in which each cage contained 15 mice, of three strains, and both sexes. Mice housed in the large group situation were placed in a bigger cage, so floor space per mouse was equal. Interaction among animals was the independent variable that was increased in the experimental condition. After 3 months, animals in the large group condition were put back into small groups. Although blood sugar in ob/ob mice did not differ from that of the control strains in the small group housing condition, blood sugar increased to diabetic levels in the large group housing condition. When animals in the large group housing condition were returned to the small group condition, blood glucose values returned to normal. Together with the classical conditioning study, we now had strong evidence that the expression of hyperglycemia in this model of type II diabetes was dependent upon exposure to stressful environmental stimuli.
We investigated the mechanism of these stress effects by examining the impact of epinephrine on plasma glucose and insulin in both lean and obese animals (45). One hour after injecting either epinephrine bitartrate (experimental group) or saline (control group) blood samples were drawn. In a manner similar to stress effects, epinephrine produced an increase in plasma glucose in all animals, with obese mice showing a greater response than their lean littermates. Further, only the obese mice showed a decrease in plasma insulin (Figure 1) . In a follow-up study, we investigated the dose-response relationship between epinephrine and hyperglycemia in ob/ob mice (49). Obese mice and their lean littermates were injected with one of three doses of epinephrine bitartrate or phentolamine mesylate. Epinephrine was administered in a dose range from 1 to 5 ju.g/10 g of body weight. Although plasma glucose responses were maximal at the lowest dose of epinephrine tested in the obese mice, there was a reliable dose response relationship between epinephrine and plasma glucose in lean mice. Moreover, phentolamine, an a-adrenergic antagonist, produced a greater increase in plasma insulin in ob/ob mice than the lean littermates, suggesting that this increased sensitivity to catecholamines may be largely mediated by changes in a-adrenergic receptors. Altered peripheral responses to sympathetic stimuli are therefore important in the exaggerated glycemic responses of ob/ob mice to stress and may be an etiologic factor in the development of diabetes in these animals. Fujimoto et al. (50) observed a similar exaggerated sensitivity to epinephrine in the KK mouse, another animal model of type II diabetes. Furthermore, they also observed that a-adrenergic blockade with phentolamine could provoke an exaggerated insulin response in KK mice compared to control mice, suggesting that KK, like ob/ob mice, have altered adrenergic sensitivity.
In human studies of this process, Linde and Deckert (51) and Robertson et al. (52) observed that a-adrenergic blockade with phentolamine increased glucose-stimulated insulin secretion in patients with type II diabetes, the latter group showing that this increase is five times greater in patients with diabetes than in normal controls. This suggests that a-adrenergic stimulation may be having a greater inhibitory effect on insulin release in diabetic patients than in normal subjects. Most recently, Kashiwagi et al. (53) demonstrated that selective blockade of a-2 receptors increased both insulin secretion and glucose disposal rate after a mixed meal in patients with type II diabetes. Also, it has been reported that glyburide, one of the sulfonylurea oral agents used to treat type II diabetes, binds to a-2 receptors in the pancreas, suggesting that one effect of this drug on insulin secretion may be due to antagonism of adrenergic activity (54).
Is altered adrenergic sensitivity a consequence of diabetes, or is it related to the development of the disease? This question was answered when we discovered that lean, nondiabetic C57BL/6J (B/6J) mice (the background strain for the ob/ob mutation) also show exaggerated glucose response to epinephrine when compared to several other strains. Furthermore, we showed that these mice develop type II diabetes when allowed to become obese on a high fat, high simple carbohydrate diet (55) (Figure 2 ). This has led us to speculate that altered sensitivity to adrenergic stimulation in the pancreas, liver, and possibly other sites as well may be related to the pathophysiology of type II diabetes (35) . In a recent investigation (56), we were able to demonstrate that lean B/6J mice had decreased sympathetic outflow to the pancreas and liver. This would be consistent with adrenergic receptor up-regulation in these tissues, which would make them more sensitive to the presence of catecholamines.
Given that mice with the genetic predisposition to develop diabetes had a supersensitivity to adrenergic stimulation, examination of humans with a similar predisposition was a logical next step. Pima Indian Native Americans are at high risk for developing type II diabetes. Approximately 60% of Pima Indian Native Americans eventually develop type II diabetes in adulthood, compared to 5% of the Caucasian population. In a recent study (57), young, euglycemic Pima Indians showed a disturbed glycemic response to behavioral stress compared to Caucasians. Pima Indians and Caucasians were given a mixed meal which was followed 2 hours later by a 10-minute mental arithmetic stressor. Although both groups showed almost identical normal glucose tolerance in response to the meal (2-hour post meal glucose was 5.6 mM), 10 of 13 Pima Indians showed a small rise in glucose after a mental arithmetic stressor, whereas seven of eight Caucasian controls did not (difference in blood glucose between Pima and Caucasian subjects after stress was 1 mM) (Figure 3) . In that both groups showed similar cardiovascular and neuroendocrine responses to the stress, it seems as though the diabetes-prone Pimas have a specific glucoregulatory defect which becomes apparent during such stimulation. These findings suggest that environmental stress, which activates the Weeks on Diet Fig. 2 . Body weight of C57BL/6] and A/J mice during overfeeding. C57BL/6J mice which were allowed to become obese developed type II diabetes. All animals were 4 weeks old on entry into study (see initial body weights). Because standard errors never exceeded 1.7 g and were in most cases <1 g, they are not shown in the graph. sympathetic nervous system, may be particularly deleterious to patients with type II diabetes and that methods to reduce the effects of stress may have some clinical utility in this disease (35) .
MOUSE MODELS IN UNDERSTANDING THE ROLE OF NUTRIENT CONTENT AND HYPERPHAGIA IN DIABETES AND OBESITY
Mouse models also allow the behavioral investigator to answer questions about the role of various nutrients and eating behavior in the development of diabetes and obesity. Weight control programs often prescribed for patients with diabetes focus on changing eating behavior under the assumption that obesity (and therefore diabetes) is somehow due to hyperphagia. Yet evidence that obesity is caused by hyperphagia is lacking. In a review of the literature, Rodin et al. (58) concluded that there was little experimental evidence to support the notion that obese people eat more than nonobese controls. Unfortunately, however, the interpretation of controlled studies on eating behavior is complicated by the Hawthorne effect; that is, that the process of observing patients' eating behavior may in and of itself influence the amount they consume. Animal models of obesity are less subject to this observational effect. They allow the investigator to ask the question as to whether or not hyperphagia is biologically necessary in the development of obesity. Slattery and Potter (59) reviewed the literature on the role of hyperphagia in spontaneous obesity in mutant mouse and rat strains, most of which also showed abnormalities in glucose metabolism. They found that, although many of these strains were hyperphagic at some point in their growth curve, obesity and diabetes would still occur if animals were pair-fed with lean controls.
In our studies of the B/6J mouse, we discovered that, although they maintain normal weight and are euglycemic when raised on standard low fat laboratory chow, they would become obese and diabetic on a high fat, high sucrose diet. In order to determine which nutrients were responsible for this diet-induced obesity, we compared the effects of fat and sucrose, separately and in combination on the diabetes and obesity-prone B/6J and diabetes and obesity-resistant A/J (60). After 4 months, the feed efficiency, or FE (weight gained/calories consumed) did not differ across diets in A/J mice, but B/6J mice showed a significantly increased FE for fat. That is, although the weight gain of A/J mice on a high fat diet could be explained simply as a function of increased caloric consumption, B/6J mice gained more weight on high fat diets than A/J mice without consuming more calories than A/J mice. Although both B/6J and A/J mice raised on a high fat diet showed similar increases in adipocyte size, only B/6J mice on high fat diets showed adipocyte hyperplasia. In the absence of fat, sucrose produced a decrease in FE in both strains. Animals fed low fat, high sucrose diets were actually leaner than animals on a high complex carbohydrate diet. Fat was also found to be the critical stimulus for hyperglycemia and hyperinsulinemia in B/6J mice. In the absence of fat, sucrose had no effect on plasma glucose or insulin. These data clearly show that obesity and diabetes will develop without hyperphagia in a genetically predisposed strain of mouse. Thus, hyperphagia is not biologically necessary to explain the development of obesity. Across these two strains of mice, genetic differences in metabolic response to fat are more important in the development of obesity and diabetes than the increased caloric content of a high fat diet. If these data can be generalized to human subjects, they may explain the failure of most weight-loss programs when obesity is treated by caloric restriction.
USE OF ANIMAL MODELS IN STUDIES OF THE GENETICS OF OBESITY AND DIABETES
Part of the difficulty in studying the genetics of type II diabetes and obesity stems from the fact that the expression of the phenotype often depends upon numerous environmental factors. For instance, it is widely believed that proper diet can prevent the expression of diabetes and obesity in individuals with the genetic predisposition (29) . Furthermore, the late onset of these diseases often makes it impossible to study the parent of the proband, making family studies difficult to carry out. Finally, type II diabetes and obesity are probably heterogeneous conditions, with different genetic factors involved in the various forms of the disease. For these reasons, genetic analysis of these human diseases continues to be a very difficult problem (61).
As described above, our work on stress hyperglycemia led to the discovery that the B/6J mouse carries a genetic predisposition to develop diabetes and obesity that is expressed on a high fat diet. This finding has very important implications for the search for diabetes and obesity genes. The recent cloning of the ob gene has stimulated an enormous interest in the role of this gene and its receptors in human obesity and diabetes. However, like humans, the B/6J mouse can become obese and diabetic with normal ob genes. It is therefore obvious that other genes are important in the development of these abnormalities. Furthermore, because the phenotypes of diabetes and obesity in B/6J mice are dependent upon environmental conditions similar to those thought to bring about diabetes in human populations, this animal is arguably an excellent genetic model of the human disease. Recent work in our laboratory has led to the identification of several putative regions on mouse chromosome 7 that seem to carry genetic factors important in the development of diabetes and obesity (62). A human homologue of one such region has recently been identified as linked to both human familial hyperinsulinemia (63) and type II diabetes (64). Identification of the specific gene(s) responsible for these problems in the B/6J mouse may therefore lead to the discovery of at least one important genetic factor for diabetes in humans.
SUMMARY
Although the stress response has long been implicated in the pathophysiology of diabetes, research in humans has been equivocal. This has led our investigative team to turn increasingly to research using animal models of this disease. Animal research has provided insight into the role of stress in diabetes through experimental control not possible in human research, as well as the examination of mechanisms by which stress can impact the disease process. The use of animal models has also led to somewhat unexpected pathways for research, such as the role of the nutrient content of food in the development and progression of diabetes. Further, an animal model has been identified which may provide important insight into the genetic aspects of diabetes. Results of animal research has pointed to possible avenues for clinical research in humans, such as the potential utility of anti-anxiety medications (65) or the use of stress management interventions with patients who are particularly stress responsive. The ultimate goal is to gain a better understanding of the mechanisms of diabetes in humans, to design better treatment modalities and, ultimately, to find a cure for this prevalent and debilitating disease. 
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